IP Library Assignment 059365/0112
Patent Assignment
Reel/Frame 059365/0112

Release of Security Interest

Recorded: 2022-03-14 Pages: 14
Assignor
Assignees
EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET, SUITE B300, WATERTOWN, MASSACHUSETTS, 02472
EYEPOINT PHARMACEUTICALS US, INC.
480 PLEASANT STREET, SUITE B300, WATERTOWN, MASSACHUSETTS, 02472
ICON BIOSCIENCE, INC.
480 PLEASANT STREET, SUITE B300, WATERTOWN, MASSACHUSETTS, 02472
Covered Properties (49)
Sustained Release Delivery Devices
Sustained Release Drug Delivery Devices
Patent: 5,902,598 →
Application: 08/919,221 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 6,217,895 →
Application: 09/273,548 →
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 6,375,972 →
Application: 09/558,207 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 6,548,078 →
Application: 09/735,636 →
Publication: US 2002/0127250
Implantable Refillable and Ported Controlled Release Drug Delivery Device
Patent: 6,852,106 →
Application: 10/013,946 →
Publication: US 2002/0138068
Device and Method for Treating Conditions of a Joint
Patent: 6,936,270 →
Application: 10/139,143 →
Publication: US 2003/0139811
Stent Coated with a Sustained-Release Drug Delivery and Method for Use Thereof
Patent: 7,279,175 →
Application: 10/245,840 →
Publication: US 2003/0108588
Injectable sustained release delivery devices
Patent: 8,871,241 →
Application: 10/714,549 →
Publication: US 2004/0176341
Bioerodible Sustained Release Drug Delivery Systems
Patent: 8,815,284 →
Application: 10/877,761 →
Publication: US 2005/0025834
Injector Apparatus and Method of Use
Patent: 7,998,108 →
Application: 11/900,907 →
Publication: US 2008/0071246
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 8,252,307 →
Application: 12/684,341 →
Publication: US 2010/0168073
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 8,574,659 →
Application: 12/688,132 →
Publication: US 2010/0119694
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 8,574,613 →
Application: 12/689,956 →
Publication: US 2010/0119580
Ocular Trocar Assembly
Patent: 8,192,408 →
Application: 12/703,634 →
Publication: US 2010/0234817
Porous Silicon Drug-Eluting Particles
Patent: 9,023,896 →
Application: 12/773,127 →
Publication: US 2010/0278931
Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
Patent: 9,333,173 →
Application: 13/286,788 →
Publication: US 2012/0177695
Injector Apparatus with Fixed Plunger and Method of Use
Patent: 8,790,293 →
Application: 13/763,587 →
Publication: US 2013/0267931
Polymer-Based, Sustained Release Drug Delivery System
Application: 13/937,844 →
Publication: US 2014/0037746
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 9,192,579 →
Application: 14/057,847 →
Publication: US 2014/0107594
Dose Guides for Injection Syringe
Application: 14/113,803 →
Publication: US 2014/0180245
Sustained Release Formulations for Delivery of Proteins to the Eye and Methods of Preparing Same
Patent: 9,814,773 →
Application: 14/124,631 →
Publication: US 2014/0140992
Sustained Release Formulations for the Treatment of Intraocular Pressure or Glaucoma
Patent: 9,283,231 →
Application: 14/168,139 →
Publication: US 2014/0213646
Drug Delivery Device Comprising Silicon-Based Carrier Particles
Application: 14/206,823 →
Publication: US 2014/0309610
Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
Patent: 9,603,801 →
Application: 14/211,170 →
Publication: US 2014/0271886
Bioerodible Sustained Release Drug Delivery Systems
Application: 14/320,940 →
Publication: US 2014/0363482
In Situ Gelling Drug Delivery System
Patent: 9,566,336 →
Application: 14/444,338 →
Publication: US 2014/0336278
Porous Silicon Drug-Eluting Particles
Patent: 9,486,459 →
Application: 14/680,430 →
Publication: US 2015/0272965
Injector Apparatus
Application: 14/850,374 →
Publication: US 2016/0074213
Use of Sustained Release Dexamethasone in Post-Cataract Surgery Inflammation
Application: 14/893,381 →
Publication: US 2016/0120879
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 9,849,085 →
Application: 14/919,962 →
Publication: US 2016/0038412
Sustained Release Formulations for the Treatment of Intraocular Pressure or Glaucoma
Patent: 9,636,347 →
Application: 15/018,461 →
Publication: US 2016/0151386
Injectable Sustained Release Intraocular Device
Application: 15/142,652 →
Publication: US 2016/0317438
Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
Patent: 9,980,911 →
Application: 15/143,283 →
Publication: US 2017/0049703
Injectable Depot Formulations
Application: 15/147,198 →
Publication: US 2016/0324836
Networked Multi-Interface Host Debugger
Application: 15/147,208 →
Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents
Application: 15/167,066 →
Publication: US 2016/0346211
Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
Patent: 9,808,421 →
Application: 15/299,050 →
Publication: US 2017/0035690
Porous silicon drug-eluting particles
Patent: 9,962,396 →
Application: 15/330,836 →
Publication: US 2017/0128464
Bioerodible Drug Delivery Devices
Application: 16/006,395 →
Publication: US 2018/0353431
Dose Guides for Injection Syringe
Application: 16/012,497 →
Publication: US 2018/0296765
Use of Sustained Release Dexamethasone in Post-Cataract Surgery Inflammation
Application: 16/018,931 →
Publication: US 2018/0303851
Sustained Release Dexamethasone Formulation
Application: 16/215,579 →
Publication: US 2019/0105330
Ocular Inserter
Patent: 851,755 →
Application: 29/543,267 →
HMGCoA reductase inhibitor-angiotensin converting enzyme inhibitor compounds
Application: 60/704,263 →
Control of induced elevated intraocular pressure
Application: 60/711,191 →
Injector apparatus and method of use
Application: 60/844,261 →
Bioerodible Drug Delivery Devices
Application: 62/518,739 →
Systems, Kits and Methods for Loading and Delivering a Small Volume Dose from a Syringe
Application: 62/628,446 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 9, 2004
From: CHEN, JIANBING; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015050/0890 →
Assignment of Assignor's Interest Aug 18, 2004
From: CHOU, KANG-JYE; GUO, HONG; ASHTON, PAUL; SHIMIZU, ROBERT W.
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015695/0061 →
Assignment of Assignor's Interest Nov 1, 2004
From: GUO, HONG; CHEN, JIANBING; SU, DONGLING; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015325/0138 →
Assignment of Assignor's Interest Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016135/0697 →
License Agreement Oct 4, 2005
From: CONTROL DELIVERY SYSTEMS, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016851/0045 →
Assignment of Assignor's Interest Aug 23, 2007
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 019746/0493 →
Assignment of Assignor's Interest Oct 16, 2007
From: NAZZARO, MARTIN; GUO, HONG; LEBLANC, RON; YORK, JOSH
To: PSIVIDA INC.
Reel/Frame 019971/0644 →
Security Agreement Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
Merger Feb 19, 2009
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 022288/0245 →
Merger Jan 26, 2010
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 023849/0476 →
Merger Jan 26, 2010
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 023849/0635 →
Assignment of Assignor's Interest Jan 26, 2010
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 023849/0540 →
Assignment of Assignor's Interest Jan 26, 2010
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 023849/0399 →
Change of Name Feb 22, 2010
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 023968/0488 →
Assignment of Assignor's Interest Mar 10, 2010
From: ASHTON, PAUL
To: PSIVIDA US, INC.
Reel/Frame 024057/0285 →
Assignment of Assignor's Interest Jun 29, 2010
From: NAZZARO, MARTIN; GUO, HONG; LEBLANC, RON; YORK, JOSH
To: PSIVIDA US, INC.
Reel/Frame 024612/0058 →
Assignment of Assignor's Interest Apr 6, 2011
From: ASHTON, PAUL; GUO, HONG; CHEN, JIANBING; CANHAM, LEIGH
To: PSIVIDA US, INC.
Reel/Frame 026080/0901 →
Change of Name Jun 27, 2011
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 026509/0447 →
Change of Name Jan 30, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 027618/0261 →
Assignment of Assignor's Interest Feb 3, 2012
From: ASHTON, PAUL; CANHAM, LEIGH; BARNETT, CHRISTIAN
To: PSIVIDIA US, INC.
Reel/Frame 027650/0456 →
Merger Apr 6, 2012
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 028007/0782 →
Change of Name Apr 6, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 028008/0214 →
Change of Name Jun 27, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 028450/0310 →
Release of Security Interest Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
Change of Name Jul 30, 2013
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 030920/0061 →